Skip to content
PBM roundup: the top 6 actions to watch
It is already shaping up to be a tough year for Pharmacy Benefit Managers (PBMs) as federal regulators and politicians work to shed light […]
PBM roundup: the top 6 actions to watch Read More »
Federal Policy
Harvard biosecurity event focuses on governance and emerging threats
On Thursday, April 20, the Harvard Kennedy School’s Belfer Center for Science and International Affairs hosted “Initiating a Renaissance in Biosecurity Governance.” The hybrid
Harvard biosecurity event focuses on governance and emerging threats Read More »
Supreme Court says mifepristone can stay – for now
After weeks of tension, the Supreme Court decided mifepristone can stay… for now. On the evening of April 21, the Supreme Court ruled the
Supreme Court says mifepristone can stay – for now Read More »
The week in mifepristone and understanding the deeper impacts
With the Texas ruling against the product mifepristone on April 7, the biotech industry came together to both denounce the ruling and help the
The week in mifepristone and understanding the deeper impacts Read More »
BIO submits comments on IRA’s Medicare Drug Price Negotiation Program
On Friday, April 14, the Biotechnology Innovation Organization (BIO) weighed in on initial guidance regarding the Drug Price Negotiation Program (Negotiation Program) under the
BIO submits comments on IRA’s Medicare Drug Price Negotiation Program Read More »
How sound tax policy can strengthen biotech
Ensuring the sustained success of the biobased economy is of great importance to continued innovation, better patient outcomes, and the economic empowerment of many
How sound tax policy can strengthen biotech Read More »
PACCARB highlights looming threat of antimicrobial resistance
In a new report, Preparing for the Next Pandemic in the Era of Antimicrobial Resistance, the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) outlined
PACCARB highlights looming threat of antimicrobial resistance Read More »
Biden administration announces $5 billion successor to Operation Warp Speed
The Biden administration announced $5 billion in federal funding will be directed to Project NextGen, the anticipated successor to Operation Warp Speed. Project NextGen
Biden administration announces $5 billion successor to Operation Warp Speed Read More »
BIO joins amicus brief against mifepristone ruling
On April 11, the Biotechnology Innovation Organization (BIO) signed on to an amicus brief calling for the suspension of a Federal District Court ruling
BIO joins amicus brief against mifepristone ruling Read More »
BIO members, chair among 400 biotech leaders opposing Texas ruling
More than 400 biotech leaders, including many Biotechnology Innovation Organization (BIO) members, have signed a statement condemning Friday’s ruling in a Texas federal court
BIO members, chair among 400 biotech leaders opposing Texas ruling Read More »